CHADI ABDALLAH to Excitatory Amino Acid Antagonists
This is a "connection" page, showing publications CHADI ABDALLAH has written about Excitatory Amino Acid Antagonists.
Connection Strength
3.122
-
Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial. Contemp Clin Trials. 2019 06; 81:11-18.
Score: 0.625
-
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018 09; 43(10):2154-2160.
Score: 0.592
-
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS. Depress Anxiety. 2016 08; 33(8):689-97.
Score: 0.507
-
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015 May; 1344:66-77.
Score: 0.470
-
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015; 66:509-23.
Score: 0.458
-
Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 2019 03 06; 101(5):774-778.
Score: 0.155
-
In vivo ketamine-induced changes in [??C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biol Psychiatry. 2015 Feb 01; 77(3):266-275.
Score: 0.112
-
Riluzole effect on occipital cortex: a structural and spectroscopy pilot study. Neurosci Lett. 2012 Nov 14; 530(1):103-7.
Score: 0.099
-
Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic. Curr Psychiatry Rep. 2017 Aug 26; 19(10):74.
Score: 0.035
-
Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression. Mol Psychiatry. 2018 04; 23(4):824-832.
Score: 0.034
-
Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov. 2017 Jul; 16(7):472-486.
Score: 0.034